Corcept Therapeutics (CORT) Tops Q2 EPS by 2c; Offers FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 71.70 -10.23 (12.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.93 | 52 Week High | $10.00 | |||
| Open | $84.98 | 52 Week Low | $3.22 | |||
| Day High | $84.98 | P/E | N/A | |||
| Day Low | $71.70 | EPS | $-0.46 | |||
| Volume | 237,918 | |||||
